Role of Type 2 Diabetes in Determining Retinal, Renal, and Cardiovascular Outcomes in Women With Previous Gestational Diabetes Mellitus
The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Women who have gestational diabetes mellitus (GDM) have elevated lifetime risks for the development of type 2 diabetes mellitus (T2DM) and cardiovascular disease (CVD), compared with their peers. However, it is not known whether their risk of CVD is dependent upon the development of T2DM. Thus, we sought to evaluate the role of T2DM in determining vascular outcomes in women with previous GDM. RESEARCH DESIGN AND METHODS: All women in Ontario, Canada, with a live-birth pregnancy between April 1994 and March 2014 (n = 1,515,079) were stratified into the following four groups: women with GDM in whom T2DM subsequently developed (n = 15,585, median age 32 years); those with GDM in whom T2DM did not develop (n = 41,299; median age 32 years); women who did not have GDM but in whom T2DM developed (n = 49,397; median age 31 years); and those with neither GDM nor T2DM (n = 1,408,798; median age 30 years). Women were followed over a median time of 10.0 years for the development of microvascular and macrovascular outcomes. RESULTS: Among women who had GDM, only those in whom T2DM developed had an increased risk of vitrectomy/photocoagulation (hazard ratio [HR] 4.49, 95% CI 3.90–5.17), renal dialysis (HR 7.52, 5.24–10.81), and hospitalization for foot infection (HR 4.32, 3.42–5.46) (all P < 0.0001). However, for macrovascular outcomes, both women with GDM in whom T2DM developed and those in whom T2DM did not develop had increased risks of CVD (HR 2.82; 2.41–3.30; P < 0.0001; and HR 1.30; 1.07–1.59; P = 0.008, respectively) and coronary artery disease (HR 3.54; 2.96–4.23; P < 0.0001; and HR 1.41; 1.11–1.80; P = 0.005, respectively), although absolute event rates were very low. CONCLUSIONS: Women with GDM have an elevated risk of cardiovascular outcomes, even in the absence of T2DM. In contrast, microvascular risk emerges only in those in whom T2DM develops.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Women with a history of GDM are at an increased risk of developing type 2 diabetes mellitus (T2DM) postpartum and also have a significantly higher risk of developing a metabolic syndrome and cardiovascular diseases compared to women with normal glucose tolerance (NGT) in pregnancy [2,3].”
Citations
Cites
Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis
Bellamy, L., Casas, J.-P., Hingorani, A. D., & Williams, D. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60731-5 · Cited by 3,253 · cited 1×
“fold higher incidence of T2DM, compared with their peers (1).”
BackgroundBuchanan, T. A., & Xiang, A. H. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200524531 · Cited by 2,123
Hux, J. E., Ivis, F., Flintoft, V., & Bica, A. (2002) · Diabetes Care · doi:10.2337/diacare.25.3.512 · Cited by 1,290 · cited 1×
“The Ontario Diabetes Database (ODD) is a validated registry of physician-diagnosed nongestational diabetes mellitus that is derived using these data (18).”
BackgroundIncreased Risk of Cardiovascular Disease in Young Women Following Gestational Diabetes Mellitus
Shah, B. R., Retnakaran, R., & Booth, G. L. (2008) · Diabetes Care · doi:10.2337/dc08-0706 · Cited by 489 · cited 1×
“In an earlier study involving 8,191 women with GDM and 81,262 control subjects, adjustment for the development of T2DM attenuated the relationship between GDM and subsequent CVD, leading to the suggestion that intervening T2DM drives the enhanced cardiovascular risk observed in this population (15).”
ResultSelf-citationCarr, D. B., Utzschneider, K. M., Hull, R. L., Tong, J., Wallace, T. M., Kodama, K., Shofer, J. B., Heckbert, S. R., Boyko, E. J., Fujimoto, W. Y., et al. (2006) · Diabetes Care · doi:10.2337/dc05-2482 · Cited by 350
Lauenborg, J., Mathiesen, E., Hansen, T., Glümer, C., Jørgensen, T., Borch-Johnsen, K., Hornnes, P., Pedersen, O., & Damm, P. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1713 · Cited by 279
Glucose Intolerance in Pregnancy and Future Risk of Pre-Diabetes or Diabetes
Retnakaran, R., Qi, Y., Sermer, M., Connelly, P. W., Hanley, A. J. G., & Zinman, B. (2008) · Diabetes Care · doi:10.2337/dc08-0972 · Cited by 251 · cited 1×
“As the incidence of impaired glucose tolerance (IGT) is known to be much higher in womenwith previous GDM than in their peers (8,21), it is possible that the po-”
BackgroundSelf-citationRetnakaran, R., & Shah, B. R. (2009) · Canadian Medical Association Journal · doi:10.1503/cmaj.090569 · Cited by 194
Self-citationGlucose Intolerance in Pregnancy and Postpartum Risk of Metabolic Syndrome in Young Women
Retnakaran, R., Qi, Y., Connelly, P. W., Sermer, M., Zinman, B., & Hanley, A. J. G. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1990 · Cited by 190 · cited 1×
“postpartum (24,28,29), suggesting a chronicity that could provide sufficient duration of exposure to contribute to atherosclerosis.”
BackgroundSelf-citationMetabolic Syndrome Risk after Gestational Diabetes: A Systematic Review and Meta-Analysis
Xu, Y., Shen, S., Sun, L., Yang, H., Jin, B., & Cao, X. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087863 · Cited by 163
Research works printed but not linked: 1
- Kralji, 2000, Measuring “rurality” for purposes of health-care planning: an empirical measure for Ontario, Ont Med Rev, 67, 33
Cited by
McIntyre, H. D., Catalano, P., Zhang, C., Desoye, G., Mathiesen, E. R., & Damm, P. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0098-8 · Cited by 1,850
Kramer, C. K., Campbell, S., & Retnakaran, R. (2019) · Diabetologia · doi:10.1007/s00125-019-4840-2 · Cited by 965
Self-citationTobias, D. K., Stuart, J. J., Li, S., Chavarro, J., Rimm, E. B., Rich-Edwards, J., Hu, F. B., Manson, J. E., & Zhang, C. (2017) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2017.2790 · Cited by 323
Li, Z., Cheng, Y., Wang, D., Chen, H., Chen, H., Ming, W.-K., & Wang, Z. (2020) · Journal of Diabetes Research · doi:10.1155/2020/3076463 · Cited by 231
McElwain, C. J., Tuboly, E., McCarthy, F. P., & McCarthy, C. M. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00655 · Cited by 208
Xie, W., Wang, Y., Xiao, S., Qiu, L., Yu, Y., & Zhang, Z. (2022) · BMJ · doi:10.1136/bmj-2022-070244 · Cited by 204
Pathophysiology from preconception, during pregnancy, and beyond.
Hivert, M.-F., Backman, H., Benhalima, K., Catalano, P., Desoye, G., Immanuel, J., McKinlay, C. J. D., Meek, C. L., Nolan, C. J., Ram, U., et al. (2024) · The Lancet · doi:10.1016/s0140-6736(24)00827-4 · Cited by 186
Adverse pregnancy outcomes and future maternal cardiovascular disease
Hauspurg, A., Ying, W., Hubel, C. A., Michos, E. D., & Ouyang, P. (2018) · Clinical Cardiology · doi:10.1002/clc.22887 · Cited by 179
“A Canadian study with 10 years of follow-up showed that women with GDM who did not subsequently develop T2DM still had 30% greater risk of CVD and 41% greater risk of CAD compared to women without GDM.20 Additionally, a prospective analysis of 2787 women in the CARDIA (Coronary Artery Risk Development in Young Adults)…”
InfluentialGestational Diabetes Mellitus and Its Implications across the Life Span
Wicklow, B. A., & Retnakaran, R. R. (2023) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2022.0348 · Cited by 171
“Kidneys Requiring renal dialysis Yes [18]”
BackgroundInfluentialSelf-citationMcKenzie‐Sampson, S., Paradis, G., Healy‐Profitós, J., St‐Pierre, F., & Auger, N. (2018) · Acta Diabetologica · doi:10.1007/s00592-017-1099-2 · Cited by 137
“Gestational diabetes is associated with a brief period of potentially intense glucose intolerance that can lead to immediate and irreversible endothelial changes [8], priming the cardiovascular system early on during a woman’s reproductive years.”
BackgroundInfluentialLai, M., Liu, Y., Ronnett, G. V., Wu, A., Cox, B. J., Dai, F. F., Röst, H. L., Gunderson, E. P., & Wheeler, M. B. (2020) · PLOS Medicine · doi:10.1371/journal.pmed.1003112 · Cited by 119
Li, J., Song, C., Li, C., Liu, P., Sun, Z., & Yang, X. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.03.054 · Cited by 124
Gunderson, E. P., Sun, B., Catov, J. M., Carnethon, M., Lewis, C. E., Allen, N. B., Sidney, S., Wellons, M., Rana, J. S., Hou, L., et al. (2021) · Circulation · doi:10.1161/circulationaha.120.047320 · Cited by 117
“Systolic blood pressure, mm Hg 113 (16) 118 (16) 123 (21) <0.”
Yu, Y., Soohoo, M., Sørensen, H. T., Li, J., & Arah, O. A. (2021) · Diabetes Care · doi:10.2337/dc21-1018 · Cited by 113
“However, studies assessing the impact of type 2 diabetes on the association between GDM and CVD have often produced inconsistent findings (5,7,13,16).”
BackgroundResultInfluentialFu, J. M., & Retnakaran, R. R. (2022) · EClinicalMedicine · doi:10.1016/j.eclinm.2022.101294 · Cited by 109
Self-citationSheiner, E., Kapur, A., Retnakaran, R. R., Hadar, E., Poon, L. C., McIntyre, D. H., Divakar, H., Staff, A. C., Narula, J., Kihara, A., et al. (2019) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.12926 · Cited by 100
Self-citationHyperglycemia in pregnancy and its implications for a woman’s future risk of cardiovascular disease
Retnakaran, R. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.04.008 · Cited by 81
Self-citationLong-term cardiovascular outcomes of gestational diabetes mellitus: a prospective UK Biobank study
Lee, S. M., Shivakumar, M., Park, J. W., Jung, Y. M., Choe, E. K., Kwak, S. H., Oh, S., Park, J. S., Jun, J. K., Kim, D., et al. (2022) · Cardiovascular Diabetology · doi:10.1186/s12933-022-01663-w · Cited by 86
Guan, Y., Song, X., Sun, W., Wang, Y., & Liu, B. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/4727283 · Cited by 84
“Patients with diabetes often develop cardiac diseases [71, 72].”
BackgroundKhan, S. R., Mohan, H., Liu, Y., Batchuluun, B., Gohil, H., Rijjal, D. A., Manialawy, Y. M., Cox, B., Gunderson, E. P., & Wheeler, M. B. (2019) · Diabetologia · doi:10.1007/s00125-018-4800-2 · Cited by 78
McIntyre, D. H., Kapur, A., Divakar, H., & Hod, M. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.614533 · Cited by 73
“In the overall population of women with Type 2 diabetes, those with antecedent GDM also appear to carry higher risks than those without such a history (76).”
BackgroundRetnakaran, R. R., & Shah, B. R. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30077-4 · Cited by 72
Self-citationThe Placental Microbiota Is Altered among Subjects with Gestational Diabetes Mellitus: A Pilot Study
Zheng, J., Xiao, X., Zhang, Q., Mao, L., Yu, M., Xu, J., & Wang, T. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00675 · Cited by 59
“Mothers with history of GDM are more likely to develop postpartum insulin resistance, dyslipidemia, and hypertension (Gobl et al., 2014), placing affected women at risk of T2DM and cardiovascular diseases later in life (Goueslard et al., 2016; Retnakaran and Shah, 2017).”
BackgroundWang, Q., Wei, S., Zhou, H., Shen, G., Gan, X., Zhou, S., Qiu, J., Shi, C., & Lu, L. (2019) · Cell Death Discovery · doi:10.1038/s41420-019-0198-y · Cited by 70
Jamilian, M., Samimi, M., Mirhosseini, N. Z., Ebrahimi, F. A., Aghadavod, E., Taghizadeh, M., & Asemi, Z. (2018) · Nutrients · doi:10.3390/nu10020163 · Cited by 68
“GDM increases the risk of type 2 diabetes mellitus (T2DM) and coronary heart disease (CHD) compared with healthy pregnant women [4].”
BackgroundGlobal burden of early pregnancy gestational diabetes mellitus (eGDM): A systematic review
Hannah, W., Bhavadharini, B., Beks, H., Deepa, M., Anjana, R. M., Uma, R., Martin, E., McNamara, K., Versace, V., Saravanan, P., et al. (2022) · Acta Diabetologica · doi:10.1007/s00592-021-01800-z · Cited by 46
Chen, A., Tan, B., Du, R., Chong, Y. S., Zhang, C., Koh, A. S.-M., & Li, L. (2024) · Cardiovascular Diabetology · doi:10.1186/s12933-024-02416-7 · Cited by 66
“Among the studies that presented CVDs outcomes in mothers, fourteen out of the 33 studies were conducted in the US [16–29], four in Canada [4, 30–32], five in Sweden [33–37], two in Iran [38, 39], three in the UK [40–42], while the remaining six were in Denmark [43], France [44], Netherlands [45],…”
BackgroundObuchowska, A., Gorczyca, K., Standyło, A., Obuchowska, K., Kimber-Trojnar, Ż., Wierzchowska-Opoka, M., & Leszczyńska‐Gorzelak, B. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158253 · Cited by 63
“Furthermore, GDM is a long-term risk factor for the development of T2DM, CVD, MS, malignant neoplasms, maternal ophthalmic, mental and renal diseases and non-alcoholic fatty liver disease [69,75,83].”
BackgroundAssociation of Gestational Diabetes With Subsequent Long-Term Risk of Mortality
Wang, Y., Mitsunami, M., Manson, J. E., Gaskins, A. J., Rich-Edwards, J. W., Wang, L., Zhang, C., & Chavarro, J. E. (2023) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2023.4401 · Cited by 63
Christensen, M. H., Rubin, K. H., Petersen, T. G., Nohr, E. A., Vinter, C. A., Andersen, M., & Jensen, D. M. (2022) · Cardiovascular Diabetology · doi:10.1186/s12933-022-01609-2 · Cited by 59
“Similar to other studies [21, 23, 24, 26, 29], our study found a significant association, regardless of subsequent diabetes.”
ResultGestational Diabetes and Incident Heart Failure: A Cohort Study
Echouffo-Tcheugui, J. B., Guan, J., Retnakaran, R. R., & Shah, B. R. (2021) · Diabetes Care · doi:10.2337/dc21-0552 · Cited by 56
Self-citationXia, X., Liang, C., Sheng, J., Yan, S., Huang, K., Li, Z., Pan, W., Tao, R., Hao, J., Zhu, B., et al. (2018) · Environmental Pollution · doi:10.1016/j.envpol.2018.01.016 · Cited by 52
Benhalima, K., Lens, K., Bosteels, J., & Chantal, M. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8091431 · Cited by 50
“2017 [3] Universal two-step screening CDA NR NR 15,585/56,884 (24.”
BackgroundZhang, Z., Zhou, Z., & Li, H. (2023) · Journal of Diabetes Investigation · doi:10.1111/jdi.14119 · Cited by 50
“Compared with the general population, the women who progress to type 2 diabetes at a younger age show a higher risk of developing renal and cardiovascular diseases, as well as non-alcoholic fatty liver disease (NAFLD), which may lead to early mortality 4,13,15,17,18,26 .”
BackgroundCanadian stroke best practice consensus statement: Secondary stroke prevention during pregnancy
Swartz, R. H., Ladhani, N. N. N., Foley, N. C., Nerenberg, K. A., Bal, S. S., Barrett, J. F. R., Bushnell, C., Chan, W., Chari, R. S., Dowlatshahi, D. D., et al. (2017) · International Journal of Stroke · doi:10.1177/1747493017743801 · Cited by 50
“women who experience gestational diabetes, the 10year risk of diabetes and cardiovascular disease is elevated.(56)”
BackgroundMaternal Arsenic Exposure and Gestational Diabetes: A Systematic Review and Meta-Analysis
Salmeri, N., Villanacci, R., Ottolina, J., Bartiromo, L., Cavoretto, P. I., Dolci, C., Lembo, R., Schimberni, M., Valsecchi, L., Viganò, P., et al. (2020) · Nutrients · doi:10.3390/nu12103094 · Cited by 47
Thyroid dysfunction during gestation and gestational diabetes mellitus: a complex relationship
Pinto, S., Croce, L., Lea, C., Cosson, E., & Rotondi, M. (2023) · Journal of Endocrinological Investigation · doi:10.1007/s40618-023-02079-3 · Cited by 44
“Moreover, women with a previous GDM display an elevated cardiovascular risk, even in the absence of development of T2D and women with a history of GDM who become diabetic after pregnancy have an increased risk of microvascular complications as compared to T2D women without a previous GDM [194, 195].”
BackgroundZhang, G., Wang, X., Zhang, X., Li, Q., Xu, S., Huang, L., Zhang, Y., Lin, L., Gao, D., Wu, M., et al. (2018) · Environment International · doi:10.1016/j.envint.2018.11.072 · Cited by 44
Cianni, G. D., Lacaria, E., Lencioni, C., & Resi, V. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.04.021 · Cited by 43
The Fourth Trimester: a Time for Enhancing Transitions in Cardiovascular Care
Choi, E., Kazzi, B. E., Varma, B., Ortengren, A. R., Minhas, A., Vaught, A. “. J., Bennett, W. L., Lewey, J., & Michos, E. D. (2022) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-022-00706-x · Cited by 42
Identifying the Critical Gaps in Research on Sex Differences in Metabolism Across the Life Span
Reusch, J. E. B., Kumar, T. R., Regensteiner, J. G., Zeitler, P. S., Participants, C., Arany, Z. P., Merz, C. N. B., Barrett-Connor, E. L., Boyle, K. E., Brown, L., et al. (2017) · Endocrinology · doi:10.1210/en.2017-03019 · Cited by 42
“Gestational diabetes Gestational diabetes confers a 7- to 12-fold increased risk for developing type 2 diabetes (T2D) in 5 to 10 years after delivery, whereas preeclampsia, preterm delivery, delivery of a small-for-gestational age neonate, and gestational diabetes are independently associated with a 50% to 300% increa…”
BackgroundKhanna, N. N., Maindarkar, M. A., Viswanathan, V., Puvvula, A., Paul, S., Bhagawati, M., Ahluwalia, P., Ruzsa, Z., Sharma, A., Kolluri, R., et al. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11226844 · Cited by 41
Mills, C. E., Govoni, V., Faconti, L., Casagrande, M., Morant, S. V., Crickmore, H., Iqbal, F., Maskell, P., Masani, A., Nanino, E., et al. (2020) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.14194 · Cited by 36
“5 Introduction 86 Type 2 diabetes mellitus (T2DM) is characterized by excess cardiac and vascular 87 disease even before ‘formal’ diagnosis [1,2].”
BackgroundShi, C., Wang, Q., Rao, Z., Shi, Y., Wei, S., Wang, H., Lu, X., Wang, P., Lü, L., Zhou, H., et al. (2020) · Annals of Translational Medicine · doi:10.21037/atm-20-1839 · Cited by 39
“Diabetes is a chronic condition that causes various complications, including atherosclerosis (24), diabetic nephropathy (25), diabetic retinopathy (26), and neural damage (22).”
Gao, L., Lin, L., Shan, N., Ren, C.-Y., Long, X. X., Sun, Y.-H., & Wang, L. (2018) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2018.1526916 · Cited by 39
Gu, Y., Dennis, S. M., Kiernan, M. C., & Harmer, A. R. (2018) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3099 · Cited by 38
Mora-Ortiz, M., & Rivas‐García, L. (2024) · Open Research Europe · doi:10.12688/openreseurope.18026.1 · Cited by 38
Gao, Y., Hu, Y., & Xiang, L. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04322-0 · Cited by 37
“It also predisposes both the mother and the infant to the development of type 2 diabetes mellitus (T2DM) [6, 7].”
BackgroundPregnancy As a Predictor of Maternal Cardiovascular Disease: The Era of CardioObstetrics
Wu, P., Mamas, M. A., & Gulati, M. (2019) · Journal of Women s Health · doi:10.1089/jwh.2018.7480 · Cited by 36
“119,120 Within the larger or more recent studies, adjustments or matching have been made for baseline age, obesity, or socioeconomic status markers.”
InfluentialVilmi‐Kerälä, T., Lauhio, A., Tervahartiala, T. I., Palomäki, O., Uotila, J. T., Sorsa, T. A., & Palomäki, A. (2017) · Cardiovascular Diabetology · doi:10.1186/s12933-017-0530-x · Cited by 34
“For instance, GDM has been shown to be associated with postpartum insulin resistance, hypertension, and dyslipidemia [3–5], placing affected women at risk of metabolic syndrome (MetS), type 2 diabetes mellitus (T2DM) and/or cardiovascular disease (CVD) later in life [5–8].”
BackgroundHewage, S. S., Wu, S., Neelakantan, N., & Yoong, J. (2019) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2019.10.011 · Cited by 33
Khan, S. R., Mohan, H., Liu, Y., Batchuluun, B., Gohil, H., Rijjal, D. A., Manialawy, Y. M., Cox, B., Gunderson, E. P., & Wheeler, M. B. (2019) · Diabetologia · doi:10.1007/s00125-019-4827-z · Cited by 33
Research Progress on Gestational Diabetes Mellitus and Endothelial Dysfunction Markers
He, Y., & Wu, N. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s295737 · Cited by 31
Christensen, M. H., Bistrup, C., Rubin, K. H., Nohr, E. A., Vinter, C. A., Andersen, M., Möller, S., & Jensen, D. M. (2023) · Diabetes Care · doi:10.2337/dc23-1092 · Cited by 31
Franzago, M., Fraticelli, F., Nicola, M. D., Bianco, F., Marchetti, D., Celentano, C., Liberati, M., Caterina, R. D., Stuppia, L., & Vitacolonna, E. (2018) · Journal of Diabetes Research · doi:10.1155/2018/9242579 · Cited by 31
“In these women, elevated markers of inflammation, decreased levels of adiponectin, increased peripheral resistance, and decreased cardiac output have been detected [11].”
BackgroundResultMao, Y., Hu, W., Xia, B., Liu, L., Han, X., & Liu, Q. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.940335 · Cited by 29
Liu, R., Zhan, Y., Liu, X., Zhang, Y., Gui, L., Qu, Y., Nan, H., & Jiang, Y. (2022) · Journal of Healthcare Engineering · doi:10.1155/2022/8948082 · Cited by 25
Retnakaran, R. R., & Shah, B. R. (2022) · BMC Medicine · doi:10.1186/s12916-022-02581-0 · Cited by 25
Self-citationWood, A. J., Boyle, J. A., Barr, E. L. M., Barzi, F., Hare, M. J. L., Titmuss, A., Longmore, D. K., Death, E., Kelaart, J., Kirkwood, M., et al. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.109092 · Cited by 24
Ngwezi, D. P., Savu, A., Yeung, R. O., Butalia, S., & Kaul, P. (2023) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2023.07.007 · Cited by 23
Towards a global consensus on GDM diagnosis: Light at the end of the tunnel?
Kapur, A., McIntyre, H. D., Divakar, H., Di Renzo, G. C., Kihara, A. B., McAuliffe, F., Hanson, M., Ma, R. C., Hod, M., & FIGO Working Group on Hyperglycemia in Pregnancy (2020) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.13149 · Cited by 22
Barrett, P., McCarthy, F. P., Evans, M., Kublickas, M., Perry, I. J., Stenvinkel, P., Kublickiene, K. R., & Khashan, A. S. (2022) · PLoS ONE · doi:10.1371/journal.pone.0264992 · Cited by 22
“Our findings are consistent with prospective studies from North America which reported that women who experience GDM, but who never develop overt T2DM, have an equivalent risk of clinically significant CKD/ESKD to those who remain normoglycaemic in pregnancy [7, 9].”
BackgroundResultGestational diabetes in young women predicts future risk of serious liver disease
Retnakaran, R. R., Luo, J., & Shah, B. R. (2018) · Diabetologia · doi:10.1007/s00125-018-4775-z · Cited by 22
Self-citationArdilouze, A., Bouchard, P., Hivert, M., Simard, C., Allard, C., Lapointe‐Garant, M., Ménard, J., Ouellet, A., Houde, G., Pesant, M.-H., et al. (2019) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2019.02.004 · Cited by 22
Hare, M. J. L., Maple-Brown, L. J., Shaw, J. E., Boyle, J. A., Lawton, P. D., Barr, E. L. M., Guthridge, S., Webster, V., Hampton, D., Singh, G., et al. (2023) · Diabetologia · doi:10.1007/s00125-023-05868-w · Cited by 21
“A previous data-linkage study from Ontario demonstrated increased risk of ESKD among women with GDM who subsequently developed type 2 diabetes [16].”
BackgroundNielsen, K. K., Vildekilde, T., Kapur, A., Damm, P., Seshiah, V., & Bygbjerg, I. C. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17093062 · Cited by 21
Retnakaran, R. R. (2021) · Metabolism · doi:10.1016/j.metabol.2021.154772 · Cited by 21
Self-citationMeng, X., Zhu, B., Liu, Y., Fang, L., Yin, B., Sun, Y., Ma, M., Huang, Y., Zhu, Y., & Zhang, Y. (2021) · Journal of Diabetes Research · doi:10.1155/2021/6689414 · Cited by 19
Birukov, A., Glintborg, D., Schulze, M. B., Jensen, T. K., Kuxhaus, O., Andersen, L. B., Kräker, K., Polemiti, E., Jensen, B. L., Jørgensen, J. S., et al. (2022) · Journal of Hypertension · doi:10.1097/hjh.0000000000003196 · Cited by 19
Mehmood, S., Ye, C., Connelly, P. W., Hanley, A. J., Zinman, B., & Retnakaran, R. R. (2018) · Cardiovascular Diabetology · doi:10.1186/s12933-018-0776-y · Cited by 19
Self-citationBauer, S., Cate, J. J. M., Whitsel, A. I., & Combs, C. A. (2022) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2022.12.315 · Cited by 18
França, D. C. H., França, E. L., Sobrevía, L., Barbosa, A. M. P., Honório‐França, A. C., & Rudge, M. V. C. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2023.166737 · Cited by 18
Gray, S. G., Sweeting, A., McGuire, T., Cohen, N. D., Ross, G. P., & Little, P. J. (2018) · Journal of Diabetes · doi:10.1111/1753-0407.12660 · Cited by 17
Rezaei, M., Błaszczyk, M., Tinkov, A. A., Binkowski, Ł. J., Mansouri, B., Skalny, A. V., Azadi, N., Doşa, M. D., & Bjørklund, G. (2021) · Environmental Science and Pollution Research · doi:10.1007/s11356-021-13927-1 · Cited by 17
Retnakaran, R. R., & Shah, B. R. (2021) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14479 · Cited by 18
Self-citationMcIntyre, H. D., Oats, J. J. N., Kihara, A. B., Divakar, H., Kapur, A., Poon, L. C., & Hod, M. (2021) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.13764 · Cited by 16
Preventing progression from gestational diabetes mellitus to diabetes: A thought‐filled review
Meron, M. K., & Grajower, M. M. (2017) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2909 · Cited by 15
BAJAJ, H. S., Ye, C., Hanley, A. J., Sermer, M., Zinman, B., & Retnakaran, R. R. (2018) · Diabetes and Vascular Disease Research · doi:10.1177/1479164118779924 · Cited by 15
Self-citationDaly, B. M., Wu, Z., Nirantharakumar, K., Chepulis, L., Rowan, J. A., & Scragg, R. K. R. (2024) · Journal of Diabetes · doi:10.1111/1753-0407.13535 · Cited by 14
“…rate for developing type 2 diabetes in women with GDM. 8,12 Twelve large population studies of mostly European women show an increased risk for women with GDM developing cardiovascular disease (CVD) from Canada, 13 – 15 the United States, 16 – 19 Europe, 20 – 23 the United Kingdom, 24 and Israel.”
BackgroundStanhewicz, A. E., Schlarmann, R. L., Brustkern, K. M., & Jalal, D. I. (2022) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00189.2022 · Cited by 14
Long‐term maternal cardiometabolic outcomes 22 years after gestational diabetes mellitus
Tutino, G., Tam, C. H., Ozaki, R., Yuen, L. Y., So, W. Y., Chan, M. H. M., Ko, G. T. C., Yang, X., Chan, J. C. N., Tam, W. H., et al. (2020) · Journal of Diabetes Investigation · doi:10.1111/jdi.13209 · Cited by 14
Long-term cardio-metabolic effects after gestational diabetes: a review
Burlina, S., Dalfrà, M. G., & Lapolla, A. (2021) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2021.1903863 · Cited by 14
Association Between Gestational Diabetes Mellitus and Future Risk of Kidney Stones
Mao, Y., Hu, W., Liu, L., & Liu, Q. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.843383 · Cited by 13
Zahid, S., Hashem, A. M., Minhas, A., Bennett, W. L., Honigberg, M. C., Lewey, J., Davis, M. B., & Michos, E. D. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.122.026786 · Cited by 13
Harreiter, J., Desoyé, G., van Poppel, M. N. M., Kautzky‐Willer, A., Dunne, F., Corcoy, R., Devlieger, R., Simmons, D. S., Adelantado, J. M., Damm, P., et al. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1282-7 · Cited by 13
Zhang, Y., Tao, Q., Cheng, Y., Fawad, M., Liang, Z., & Xu, X. (2024) · Annals of Epidemiology · doi:10.1016/j.annepidem.2024.09.002 · Cited by 12
Mussa, J., Rahme, E., Dahhou, M., Nakhla, M. M., & Dasgupta, K. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110998 · Cited by 12
Liang, W., & Sun, F. (2023) · Journal of Endocrinological Investigation · doi:10.1007/s40618-023-02233-x · Cited by 12
“Several studies have demonstrated that GDM independently increases the risk of adverse pregnancy outcomes, even in the absence of pre-existing diabetes [5, 9, 18, 22, 23].”
Harville, E. W., Bazzano, L., Qi, L., He, J., DORANS, K. S., Perng, W., & Kelly, T. N. (2020) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2020.06.015 · Cited by 11
“This is consistent with the women with a history of GDM but not active diabetes having milder disturbances, rather than the whole pathway being disturbed, as would be seen with T2DM.”
BackgroundInfluentialSimon, J., Goueslard, K., Bechraoui‐Quantin, S., Arveux, P., & Quantin, C. (2021) · Biomedicines · doi:10.3390/biomedicines9091174 · Cited by 11
“Thus, several studies have shown that GDM increased the risk of type 2 diabetes [14,16], and type 2 diabetes is recognized as increasing the risk of BC [43].”
BackgroundLorenz, A., Oza‐Frank, R. B., May, S., Conrey, E. J., Panchal, B. D., Brill, S. B., RajanBabu, A., & Howard, K. (2019) · Primary care diabetes · doi:10.1016/j.pcd.2019.09.010 · Cited by 10
Gupta, Y., Kapoor, D., Lakshmi, J. K., Praveen, D., Santos, J. A., Billot, L., Naheed, A., de Silva, H. A., Gupta, R., Farzana, N., et al. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110893 · Cited by 10
Retnakaran, R. R., Ye, C., Hanley, A. J., Connelly, P. W., Sermer, M., & Zinman, B. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.119.014231 · Cited by 10
Self-citationAstbury, N. M., Ripullone, K., Ramakrishnan, R., Woodward, M., & Hirst, J. E. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70210 · Cited by 9
FIELD, C. P., Grobman, W. A., Mast, D. D. D., Wu, J., Vickers, S., Csizmadia, V., Bartholomew, A. B. C., Chen, A., Mullangi, V. N., Gabbe, S. G., et al. (2026) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000006236 · Cited by 9
Jiang, Z., Ye, X., Cao, D., Xiang, Y., & Li, Z. (2023) · Reproductive Sciences · doi:10.1007/s43032-023-01353-2 · Cited by 9
“In comparison to women with healthy pregnancies, those who have a history of GDM are more susceptible to developing cardiovascular disease, retinal disease, and kidney disease, as reported in studies [27, 28].”
Jin, H. (2019) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2019.8336 · Cited by 9
“In pregnant females with impaired insulin secretion, smooth acceleration of insulin secretion may not be possible, leading to abnormal glucose metabolism and onset of GDM (18,19).”
BackgroundScavini, M., Formoso, G., Festa, C., Sculli, M. A., Succurro, E., Sciacca, L., & Torlone, E. (2020) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3411 · Cited by 9
Shah, B. R., Feig, D. S., Herer, E., Hladunewich, M., Kiss, A., Kohly, R. P., Lipscombe, L. L., Yip, P. S. F., & Cherney, D. Z. I. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.109068 · Cited by 8
Self-citationYee, K. H., Tan, K. H., Aris, I. M., Lamoureux, E. L., Chong, Y. S., Wang, J. J., Wong, T. Y., & Li, L. (2019) · Diabetic Medicine · doi:10.1111/dme.13928 · Cited by 8
Metadata
- Authors
- Retnakaran, R., & Shah, B. R.
- Affiliations
- Mount Sinai Hospital (CA)
- Sunnybrook Health Science Centre (CA)
- Corresponding author
- Shah, Baiju R.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2016-11-07
- Volume
- 40
- Issue
- 1
- Pages
- 101-108
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2553073169
- Cited by
- 167
- References
- 33
- Citations by year
- 2026: 14 · 2025: 16 · 2024: 15 · 2023: 16 · 2022: 23 · 2021: 18 · 2020: 16 · 2019: 20 · 2018: 19 · 2017: 10
- FWCI
- 21.06
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- gestational diabetes mellitus, type 2 diabetes, cardiovascular disease, diabetic retinopathy, diabetic nephropathy, dialysis, foot infection, coronary artery disease, microvascular complications, macrovascular complications, women, diabetes risk stratification, live birth, hospitalization, vitrectomy, photocoagulation, coronary angiography
- MeSH terms
- Adult, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Female, Humans, Kidney Diseases, Ontario, Pregnancy, Retinal Diseases, Risk Factors, Time Factors, Proportional Hazards Models, Case-Control Studies, Diabetes, Gestational, Postpartum Period, Microvessels
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.